As of the latest Form 4 filed Jul 9, 2026.
What Privia Health Group Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 27 most recent filings for PRVA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-07 | Mountcastle David EVP & Chief Financial Officer | SSale | −600.00 | $27.57 | $16.5K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-06 | Morris Matthew Shawn Director | SSale | −53.7K | $27.24 | $1.46M | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-06 | Morris Matthew Shawn, Director | MExercise | +53.7K | $2.00 | $107K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Mountcastle David EVP & Chief Financial Officer | SSale | −24.7K | $27.50 | $680K | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Morris Matthew Shawn Director | SSale | −59.0K | $27.33 | $1.61M | Yes (planned) | Form 4 ↗ |
| 2026-07-07 | 2026-07-02 | Morris Matthew Shawn, Director | MExercise | +59.0K | $2.00 | $118K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Morris Matthew Shawn Director | SSale | −37.0K | $26.93 | $998K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Morris Matthew Shawn, Director | SSale | −45.6K | $26.52 | $1.21M | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-07-01 | Morris Matthew Shawn, Director | MExercise | +82.7K | $2.00 | $165K | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Morris Matthew Shawn, Director | SSale | −52.8K | $25.72 | $1.36M | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Morris Matthew Shawn, Director | MExercise | +52.8K | $2.00 | $106K | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-29 | Morris Matthew Shawn Director | SSale | −63.2K | $25.33 | $1.60M | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-29 | Morris Matthew Shawn, Director | MExercise | +63.2K | $2.00 | $126K | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Morris Matthew Shawn, Director | SSale | −88.1K | $25.33 | $2.23M | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Morris Matthew Shawn, Director | MExercise | +88.1K | $2.00 | $176K | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | SSale | −17.2K | $25.18 | $433K | Yes (planned) | Form 4 ↗ |
| 2026-06-30 | 2026-06-26 | Mountcastle David, EVP & Chief Financial Officer | MExercise | +17.2K | $2.00 | $34.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-13 | 2026-05-12 | Mehrotra Parth Chief Executive Officer | SSale | −15.6K | $22.64 | $354K | Yes (planned) | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Mountcastle David EVP & Chief Financial Officer | SSale | −3.38K | $22.60 | $76.5K | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Mehrotra Parth Chief Executive Officer | SSale | −105K | $22.55 | $2.38M | Yes (planned) | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Mountcastle David EVP & Chief Financial Officer | SSale | −5.57K | $20.85 | $116K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Mehrotra Parth Chief Executive Officer | SSale | −26.5K | $22.11 | $586K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Mountcastle David EVP & Chief Financial Officer | SSale | −6.39K | $22.11 | $141K | No | Form 4 ↗ |
| 2024-05-02 | 2024-04-30 | Mountcastle David EVP & Chief Financial Officer | SSale | −2.32K | $18.42 | $42.7K | No | Form 4 ↗ |
| 2024-05-02 | 2024-04-30 | Bartrum Thomas Insider | SSale | −2.25K | $18.42 | $41.5K | No | Form 4 ↗ |
| 2024-05-02 | 2024-04-30 | Mehrotra Parth Chief Executive Officer | SSale | −12.2K | $18.42 | $225K | No | Form 4 ↗ |
| 2024-05-02 | 2024-04-30 | Morris Matthew Shawn Director | SSale | −11.1K | $18.42 | $204K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also PRVA’s full analysis or the market-wide insider trading feed. The tabs above jump to PRVA’s other SEC data.
Source: SEC Form 4 filings for PRVA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.